Publications

Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled tri...

Leach, AJ; MULHOLLAND, EK; Santosham, M; Torzillo, PJ; McIntyre, P; Smith-Vaughan, H; Wilson, N; Arrowsmith, B; Beissbarth, J; Chatfield, MD; Oguoma, VM; Licciardi, P; Skull, S; Andrews, R; Carapetis, J; McDonnell, J; Krause, V; Morris, PS;

2021

Vaccine: X, (2021).7, 10.1016/j.jvacx.2021.100086.

How can early stage economic evaluation help guide research for future vaccines?.

Newall, AT; Beutels, P; Tuffaha, HW; Hall, PS; JIT, M;

2021

Vaccine, (2021).40 2 10.1016/j.vaccine.2021.11.017.

Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0-4 years.

Thysen, SM; Fisker, AB; Byberg, S; Aaby, P; Roy, P; WHITE, R; Griffiths, U; Harris, RC;

2021

BMJ global health, (2021).6 8 10.1136/bmjgh-2021-006127.

A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Olsen, AW; Rosenkrands, I; HOLLAND, MJ; Andersen, P; Follmann, F;

2021

NPJ vaccines, (2021).6 1 10.1038/s41541-021-00312-9.

Durable natural killer cell responses after heterologous two-dose Ebola vaccination.

Wagstaffe, HR; Susannini, G; Thiébaut, R; Richert, L; Lévy, Y; Bockstal, V; Stoop, JN; Luhn, K; Douoguih, M; Riley, EM; Lacabaratz, C; GOODIER, MR;

2021

npj Vaccines, (2021).6 1 10.1038/s41541-021-00280-0.

Better data for country-level TB resource allocation are urgently required.

Clarkson, MC; MCQUAID, CF; HOUBEN, RM; KRANZER, K; WHITE, RG;

2021

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2021).25 8 10.5588/ijtld.20.0912.

Multivalent poultry vaccine development using Protein Glycan Coupling Technology.

MAURI, M; Sannasiddappa, TH; Vohra, P; Corona-Torres, R; Smith, AA; Chintoan-Uta, C; Bremner, A; TERRA, VS; ABOUELHADID, S; Stevens, MP; Grant, AJ; CUCCUI, J; WREN, BW; Glycoengineering of Veterinary Vaccines Consortium,;

2021

Microbial cell factories, (2021).20 1 10.1186/s12934-021-01682-4.

Assessing COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: A Global Social Listening Study.

Hou, Z; Tong, Y; Du, F; Lu, L; Zhao, S; Yu, K; Piatek, SJ; LARSON, HJ; LIN, L;

2021

Journal of medical Internet research, (2021).23 6 10.2196/27632.

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Wouters, OJ; Shadlen, KC; Salcher-Konrad, M; Pollard, AJ; LARSON, HJ; Teerawattananon, Y; JIT, M;

2021

Lancet (London, England), (2021).397 10278 10.1016/S0140-6736(21)00306-8.

Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.

Hotez, PJ; Batista, C; Amor, YB; Ergonul, O; Figueroa, JP; Gilbert, S; Gursel, M; Hassanain, M; Kang, G; Kaslow, DC; Kim, JH; Lall, B; LARSON, H; Naniche, D; Sheahan, T; Shoham, S; WILDER-SMITH, A; Sow, SO; Strub-Wourgaft, N; Yadav, P; Bottazzi, ME;

2021

EClinicalMedicine, (2021).39, 10.1016/j.eclinm.2021.101053.